Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06743425 · ClinicalTrials.gov registry record · NA

A Pilot Study of a Remote ADHD Monitoring Program

A NA study of Attention Deficit Hyperactivity Disorder and ADHD, sponsored by IDeA States Pediatric Clinical Trials Network.

Recruiting
Registry status
NA
Development phase
36
Enrollment target
2
Study locations

NCT06743425: Recruiting NA study of Attention Deficit Hyperactivity Disorder and ADHD, sponsored by IDeA States Pediatric Clinical Trials Network.

NCT06743425 is a NA study of Attention Deficit Hyperactivity Disorder and ADHD that is actively recruiting participants, run by IDeA States Pediatric Clinical Trials Network. The registered enrollment target is 36 participants, below the 216-participant average among 102 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (83% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06743425, a NA study of Attention Deficit Hyperactivity Disorder and ADHD, is actively recruiting participants, sponsored by IDeA States Pediatric Clinical Trials Network.

RECRUITING
Registry status
NA
Development phase
36 participants
Enrollment target
2
Study locations

Study Summary

RAMP is a pilot study examining the use of an Attention-Deficit/Hyperactivity Disorder (ADHD) Monitoring Program during the early stages of treating ADHD in children living in rural settings. This trial will enroll 36 caregiver/infant dyads across 2 sites and will evaluate feasibility endpoints rather than clinical outcomes. Enrolled participants will be randomized 1:1 to the intervention group (RAMP reports) or control group (digital education handouts). The study duration is 10 months, including start-up, enrollment and intervention, and data analysis and manuscript submission.

Primary Outcome

The number of clinical assessments (paper assessments in control and RAMP Reports in intervention) per participant that are completed by caregivers and teachers and returned to providers for ADHD management.

Conditions Studied

Attention Deficit Hyperactivity Disorder ADHD

Interventions

  • OTHER RAMP Reports
  • OTHER Digital Education Handouts

Study Locations (2)

Mississippi

  • University of Mississippi Medical Center - Jackson

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2025-02-04
Est. Completion 2026-07-01
Phase NA
IDeA States Pediatric Clinical Trials Network

7 total trials

What NCT06743425 shows while recruiting

NCT06743425 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 216-participant average among 102 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (83% lower).

The record links to 2 conditions, with Attention Deficit Hyperactivity Disorder appearing as the primary indexed condition, and to 2 interventions - of which RAMP Reports is the first listed.

NCT06743425 reports a single indexed study location in Mississippi, South Carolina.

Frequently Asked Questions

What is clinical trial NCT06743425 about?

NCT06743425 is a clinical study titled "A Pilot Study of a Remote ADHD Monitoring Program". RAMP is a pilot study examining the use of an Attention-Deficit/Hyperactivity Disorder (ADHD) Monitoring Program during the early stages of treating ADHD in children living in rural settings. This trial will enroll 36 caregiver/infant dyads across 2 sites and will evaluate feasibility endpoints rath...

What is the current status of trial NCT06743425?

This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2025-02-04. Estimated completion is 2026-07-01.

What conditions does trial NCT06743425 study?

This clinical trial studies the following conditions: Attention Deficit Hyperactivity Disorder, ADHD.

What interventions are being tested in trial NCT06743425?

The interventions under investigation include: RAMP Reports (OTHER), Digital Education Handouts (OTHER).

Who is sponsoring clinical trial NCT06743425?

This trial is sponsored by IDeA States Pediatric Clinical Trials Network, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06743425 being conducted?

This trial has 2 study locations across Mississippi, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Attention Deficit Hyperactivity Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06743425's enrollment target sits among peer trials

36 75th of 102 higher than 27 of 102 other Attention Deficit Hyperactivity Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Attention Deficit Hyperactivity Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06743425

Source: ClinicalTrials.gov NCT06743425, the US trial registry maintained by the National Library of Medicine. NCT06743425 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.